Post

Inflammation among current dementia research focus, says Alchemab CSO

Inflammation, cell metabolism and neuronal health are current key areas of focus for dementia researchers, according to Jane Osbourn, chief …

Comprehensive clinical trial services 

Comprehensive clinical trial services: Introduction  In the intricate and highly regulated world of clinical research, selecting the right clinical trial services …

Denali Therapeutics gets grant for polypeptides targeting transferrin receptor for brain delivery

Denali Therapeutics has patented a method to generate polypeptides that target transferrin receptor-expressing cells, including those across the blood-brain barrier. …

Cue Biopharma gets grant for fusion polypeptide with variant IL-2 and antibody fc region

Cue Biopharma has been granted a patent for variant immunomodulatory polypeptides and fusion polypeptides, including T-cell modulatory multimeric polypeptides. The …

Tenaya Therapeutics gets grant for compound for treating diseases by inhibiting HDAC6 activity

Tenaya Therapeutics has been granted a patent for compounds that inhibit HDAC6 activity, potentially treating various diseases. The formula for …